(Q34743096)

4 August 2017

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup (English)

1 reference

4 August 2017

1 reference

R L Souhami

1

1 reference

4 August 2017

A W Craft

2

1 reference

4 August 2017

J W Van der Eijken

3

1 reference

4 August 2017

M Nooij

4

1 reference

4 August 2017

D Spooner

5

1 reference

4 August 2017

V H Bramwell

6

1 reference

4 August 2017

R Wierzbicki

7

1 reference

4 August 2017

A J Malcolm

8

1 reference

4 August 2017

A Kirkpatrick

9

1 reference

4 August 2017

B M Uscinska

10

1 reference

4 August 2017

M Van Glabbeke

11

1 reference

4 August 2017

D Machin

12

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

4 August 2017

1 reference

4 August 2017

350

1 reference

4 August 2017

911-917

1 reference

4 August 2017

9082

1 reference

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

The role of methotrexate in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Methotrexate pharmacokinetics and prognosis in osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2902307-6

7 January 2021

10.1016/S0140-6736(97)02307-6

Identifiers

DOI

1 reference

4 August 2017

1 reference